Mesenchymal Stem Cells for Coronavirus (COVID-19)-Induced Pneumonia: Revisiting the Paracrine Hypothesis with New Hopes?

Mesenchymal stem cells (MSCs) bear a promising potential for regenerative medicine therapies and they repair damaged tissue through secretion of immune modulatory and anti-inflammatory molecules acting in a paracrine fashion Coronavirus disease 2019 (COVID-19) has spread all over the world with high morbidity and mortality rates and there is no specific treatment for this infection A recent study published in the journal reports that MSC infusion is safe and effective in patients suffering from COVID-19 induced pneumonia In the light of this study and previous reports, we make additional comments about possible therapeutic effects of MSCs in COVID-19 infection